Softcare Limited (02698) reported no changes to its authorised or issued share capital for March 2026, maintaining 1.00 billion authorised ordinary shares at a par value of USD 0.0001, equivalent to USD 100,000 in authorised capital. Issued shares remained at 620.77 million with no treasury shares outstanding.

The company confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement of 15 percent as at 31 March 2026.

Share-based incentives were largely unchanged: • Pre-IPO Share Option Scheme (adopted 15 January 2025): 1.06 million options outstanding; potential issuance of 66,507 new shares if fully exercised. • Post-IPO Share Option Scheme (adopted 27 October 2025): no options granted to date, leaving capacity for up to 60.59 million shares. • No warrants, convertible securities or other equity-linked instruments were outstanding.

No shares were issued, repurchased, or cancelled during the month, and no funds were raised from option exercises.

The filing was authorised by Joint Company Secretary Ms Lung Shei Kei and submitted to Hong Kong Exchanges and Clearing Limited on 7 April 2026.